Optimark and nephrogenic fibrosing dermopathy Patient Reports February 11, 2012

Optimark Side Effects Report #5283681-2
Optimark side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 14, 2007. Male patient, 71 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Optimark. After drug was administered, patient experienced the following side effects: nephrogenic fibrosing dermopathy. Optimark dosage: unknown. Patient recovered.

Optimark Side Effects Report #5298535-5
Optimark side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 27, 2007. Male patient, 71 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Optimark. After drug was administered, patient experienced the following side effects: nephrogenic fibrosing dermopathy. Optimark dosage: unknown. Patient recovered.

Optimark Side Effects Report #5093649-7
Optimark side effect was reported by a Physician from UNITED STATES on Aug 15, 2006. Male patient, 67 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Optimark. After drug was administered, patient experienced the following side effects: nephrogenic fibrosing dermopathy, peritoneal dialysis. Optimark dosage: unknown. Patient recovered.

Optimark Side Effects Report #5093648-5
Optimark side effect was reported by a Physician from UNITED STATES on Aug 15, 2006. Female patient, 55 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Optimark. After drug was administered, patient experienced the following side effects: nephrogenic fibrosing dermopathy. Optimark dosage: unknown. During the same period patient was treated with LEXAPRO, QUININE SULPHATE, BICARBONATE IN PLASTIC CONTAINER, BENADRYL. Patient recovered.


Optimark Side Effects Report #5117145-3
Optimark side effect was reported by a Health Professional from UNITED STATES on Sept 27, 2006. Female patient, 55 years of age, weighting 222.7 lb, was diagnosed with myocardial infarction and was treated with Optimark. After drug was administered, patient experienced the following side effects: arthralgia, nephrogenic fibrosing dermopathy, pain in extremity, post procedural complication. Optimark dosage: 32 ML IV. Patient recovered.

Optimark Side Effects Report #5316350-0
Optimark side effect was reported by a Physician from UNITED STATES on Apr 13, 2007. Male patient, 62 years of age, was diagnosed with angiogram, nuclear magnetic resonance imaging and was treated with Optimark. After drug was administered, patient experienced the following side effects: arterial stenosis, nephrogenic fibrosing dermopathy, osteomyelitis, peritoneal dialysis. Optimark dosage: unknown. During the same period patient was treated with OPTIMARK IN GLASS VIALS, OPTIMARK IN GLASS VIALS, OPTIMARK IN GLASS VIALS. Patient recovered.

Optimark Side Effects Report #5316349-4
Optimark side effect was reported by a Physician from UNITED STATES on Apr 13, 2007. Female patient, 55 years of age, was treated with Optimark. After drug was administered, patient experienced the following side effects: haemodialysis, nephrogenic fibrosing dermopathy. Optimark dosage: unknown. During the same period patient was treated with OPTIMARK IN GLASS VIALS, OPTIMARK IN GLASS VIALS, LEXAPRO, QUININE SULPHATE, AVAPRO, SINGULAIR, FOLATE, PERCOCET. Patient recovered.

Optimark Side Effects Report #5286028-0
Optimark side effect was reported by a Physician from UNITED STATES on Mar 16, 2007. Male patient was treated with Optimark. After drug was administered, patient experienced the following side effects: nephrogenic fibrosing dermopathy. Optimark dosage: unknown. During the same period patient was treated with OMNISCAN. Patient recovered.